Genomic Health director Julian Baker buys 407,297 shares

By Lisa Kerner

Charlotte, N.C., June 11 - Genomic Health, Inc. director Julian C. Baker and his affiliates, including Felix J. Baker and Baker Bros. Investments, LLP, reported the purchase of 407,297 shares of the company's stock in a schedule 13D filed with the Securities and Exchange Commission.

The shares were acquired between June 5 and June 9 priced from $19.50 to $20.20 each, according to the filing.

The reporting persons beneficially own 5,390,784 shares, or 19.1%, of the Redwood City, Calif., biotechnology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.